GLUTAMATE AND PARKINSONS-DISEASE

[1] THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J]. TRENDS IN NEUROSCIENCES, 1989, 12 (10) : 366 - 375

[2] ALTERNATIVE EXCITOTOXIC HYPOTHESES [J]. NEUROLOGY, 1992, 42 (04) : 733 - 738

[3] REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J]. SCIENCE, 1990, 249 (4975) : 1436 - 1438

[4] CHEN HSV, 1992, J NEUROSCI, V12, P4427

[5] ELECTRICAL TO CHEMICAL TRANSMISSION IN THE CENTRAL NERVOUS-SYSTEM [J]. NOTES AND RECORDS OF THE ROYAL SOCIETY OF LONDON, 1976, 30 (02): : 219 - &

[6] ANTIPARKINSONIAN EFFECTS OF REMACEMIDE HYDROCHLORIDE, A GLUTAMATE ANTAGONIST, IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE [J]. ANNALS OF NEUROLOGY, 1994, 35 (06) : 655 - 661

[7] THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS [J]. ANNALS OF NEUROLOGY, 1991, 30 (05) : 717 - 723

[8] TOWARD AN UNDERSTANDING OF THE ROLE OF GLUTAMATE IN EXPERIMENTAL PARKINSONISM - AGONIST-SENSITIVE SITES IN THE BASAL GANGLIA [J]. ANNALS OF NEUROLOGY, 1993, 34 (04) : 585 - 593

[9] NMDA ANTAGONISTS POTENTIATE ANTIPARKINSONIAN ACTIONS OF L-DOPA IN MONOAMINE-DEPLETED RATS [J]. ANNALS OF NEUROLOGY, 1990, 28 (04) : 539 - 546

[10] THERAPEUTIC POTENTIAL OF EXCITATORY AMINO-ACID ANTAGONISTS - CHANNEL BLOCKERS AND 2,3-BENZODIAZEPINES [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (09) : 325 - 331

[1] THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J]. TRENDS IN NEUROSCIENCES, 1989, 12 (10) : 366 - 375

[2] ALTERNATIVE EXCITOTOXIC HYPOTHESES [J]. NEUROLOGY, 1992, 42 (04) : 733 - 738

[3] REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J]. SCIENCE, 1990, 249 (4975) : 1436 - 1438

[4] CHEN HSV, 1992, J NEUROSCI, V12, P4427

[5] ELECTRICAL TO CHEMICAL TRANSMISSION IN THE CENTRAL NERVOUS-SYSTEM [J]. NOTES AND RECORDS OF THE ROYAL SOCIETY OF LONDON, 1976, 30 (02): : 219 - &

[6] ANTIPARKINSONIAN EFFECTS OF REMACEMIDE HYDROCHLORIDE, A GLUTAMATE ANTAGONIST, IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE [J]. ANNALS OF NEUROLOGY, 1994, 35 (06) : 655 - 661

[7] THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS [J]. ANNALS OF NEUROLOGY, 1991, 30 (05) : 717 - 723

[8] TOWARD AN UNDERSTANDING OF THE ROLE OF GLUTAMATE IN EXPERIMENTAL PARKINSONISM - AGONIST-SENSITIVE SITES IN THE BASAL GANGLIA [J]. ANNALS OF NEUROLOGY, 1993, 34 (04) : 585 - 593

[9] NMDA ANTAGONISTS POTENTIATE ANTIPARKINSONIAN ACTIONS OF L-DOPA IN MONOAMINE-DEPLETED RATS [J]. ANNALS OF NEUROLOGY, 1990, 28 (04) : 539 - 546

[10] THERAPEUTIC POTENTIAL OF EXCITATORY AMINO-ACID ANTAGONISTS - CHANNEL BLOCKERS AND 2,3-BENZODIAZEPINES [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (09) : 325 - 331